VYNE - VYNE Therapeutics Inc
IEX Last Trade
1.835
0.025 1.362%
Share volume: 20,012
Last Updated: Fri 30 Aug 2024 09:59:19 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.81
0.03
1.38%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-14 | 2023-03-14 | 2023-05-11 | 2023-08-14 | 2023-11-13 | 2024-03-01 | 2024-05-09 | |
| Total revenue | 126.000 K | 167.000 K | 6.000 K | 99.000 K | 135.000 K | 114.000 K | 76.000 K | 98.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 126.000 K | 167.000 K | 6.000 K | 99.000 K | 135.000 K | 114.000 K | 76.000 K | 98.000 K | |
| 32.54% | -96.41% | 1,550.00% | 36.36% | -15.56% | -33.33% | 28.95% | |||
| Operating expenses | 8.413 M | 9.500 M | 7.990 M | 5.974 M | 10.453 M | 6.348 M | 6.907 M | 7.478 M | |
| Selling general and admin | 4.305 M | 3.954 M | 3.711 M | 3.240 M | 3.220 M | 3.030 M | 3.885 M | 3.770 M | |
| Research and development | 4.108 M | 5.546 M | 4.279 M | 2.734 M | 7.233 M | 3.318 M | 3.022 M | 3.708 M | |
| Total expenses | 8.413 M | 9.500 M | 7.990 M | 5.974 M | 10.453 M | 6.348 M | 6.907 M | 7.478 M | |
| 12.92% | -15.89% | -25.23% | 74.97% | -39.27% | 8.81% | 8.27% | |||
| Operating income | -8.287 M | -9.333 M | -7.984 M | -5.875 M | -10.318 M | -6.234 M | -6.831 M | -7.380 M | |
| Ebit | -8.287 M | -9.333 M | -7.984 M | -5.875 M | -10.318 M | -6.234 M | -6.831 M | -7.380 M | |
| Pretax income | -8.235 M | -9.255 M | -7.748 M | -5.612 M | -10.038 M | -6.071 M | -6.151 M | -6.241 M | |
| 12.39% | -16.28% | -27.57% | 78.87% | -39.52% | 1.32% | 1.46% | |||
| Income tax | 0.000 | 0.000 | 13.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -8.476 M | -9.459 M | -9.945 M | -5.622 M | -10.058 M | -6.584 M | -6.188 M | -6.249 M | |
| -11.60% | -5.14% | 43.47% | -78.90% | 34.54% | 6.01% | -0.99% | |||
| Net income | -8.476 M | -9.459 M | -9.945 M | -5.622 M | -10.058 M | -6.584 M | -6.188 M | -6.249 M | |
| -11.60% | -5.14% | 43.47% | -78.90% | 34.54% | 6.01% | -0.99% |